ScholarIQanswers from OpenAlex

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

PaperCitations, authors & open-access status

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go have?

ScholarIQcitation count

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go has 176 citations in the OpenAlex counts ScholarIQ stores.

When was Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go published?

ScholarIQyear

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go has 2021 year in the ScholarIQ index.

What is the open-access status of Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go?

ScholarIQoa status

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go has closed oa status in the ScholarIQ index.

What is the DOI of Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go?

ScholarIQdoi

The DOI for Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go is on the source record.

What is the PMID of Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go?

ScholarIQpmid

The PMID for Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go is on the source record.

What is the OpenAlex record for Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go?

ScholarIQopenalex

The OpenAlex for Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial